pH 7.0 with 10 mg/L of sodium azide) lacking dextran to serve as controls. The tubes were allowed to rotate for 20 hours. The tubes were subsequently subjected to centrifugation and the supernatant solutions were filtered through a 0.22 µm membrane (Millex® Syringe Filter Units, Millex®-GV, 0.22 µm, PVDF, 33 mm, gamma sterilized, catalogue number: SLGV033RB, EMD Millipore Corporation, Billerica, MA, 01821, USA) in order to remove any activated carbon particles that might remain suspended in solution. The compositions of the resulting solutions were determined by analytical size exclusion chromatography as described in Experimental Section 2.4. Size exclusion chromatograms for the activated carbon treated buffer solutions are shown in Figure S1a . The normalized RI detector response at specific molecular weights for the dextran treated solutions plotted as a function of the volume of activated carbon added are shown in Figure S1b . The Δnormalized RI detector response/Δactivated carbon volume values listed in Table S1 are the average of three measurements.
Figure S1a. Buffer (50 mM potassium phosphate at pH 7.0 with 10 mg/L of sodium azide) without dextran that was treated with increasing amounts of Nuchar HD activated carbon under static conditions. Note that the control buffer solutions showed a peak that increased with increasing amounts of activated carbon. This peak might be attributed to the leaching of small amounts residual salt from the process of manufacturing the activated carbon. Rinsing the activated carbon with copious amount of water reduced, but did not eliminate, the peak. The peak does not influence any of the molecular weights examined except 1,000 Da. The effect on this peak is < 4% and does not change the overall trend that is observed. Figure S1b . The normalized RI detector response at 1,000 Da, 3,500 Da, 10,000 Da, 40,000 Da, 70,000 Da, 500,000 Da, and 2,000,000 Da as a function of the volume of activated carbon added. Table S1 . The Δnormalized RI detector response/Δactivated carbon volume represents the ability of Nuchar HD activated carbon to adsorb a specific molecular weight of dextran. pss-psskit, Polymer Standards Service-USA, Inc., Warwick, RI 02888) were prepared at a concentration of 1.0 mg/mL by dissolving 40 mg of the polymer in 40 mL of 25 mM Tris-HCl at pH 7.0. The standards had weight average molecular weights of 1,100 Da, 3, 610 Da, 6, 520 Da, 14, 900 Da, 32, 900 Da, 63, 900 Da, 148, 000 Da, 282, 000 Da, 666 ,000 Da, and 976,000 Da.
Three 15 mL centrifuge tubes for each molecular weight were loaded with 12 mg of Nuchar HD activated carbon (lot number: 1339-R-09, MeadWestVaco Corporation, Richmond, VA, USA). Three separate 15 mL centrifuge tubes for each molecular weight were used as controls and no activated carbon was added. To all tubes was added 2.5 mL of buffer (25 mM
Tris-HCl at pH) and then the tubes were subjected to vortexing. Next 2.5 mL of the sulfonated polystyrene stock solution at 1.0 mg/mL in Tris-HCl at pH 7.0 was added to all tubes. The resulting solutions had a sulfonated polystyrene concentration of 0.5 mg/mL.
The tubes were allowed to rotate for 20 hours at room temperature. The tubes were subsequently subjected to centrifugation and the supernatant solutions were filtered through a 0.22 µm membrane (Millex® Syringe Filter Units, Millex®-GV, 0.22 µm, PVDF, 33 mm, gamma sterilized, catalogue number: SLGV033RB, EMD Millipore Corporation, Billerica, MA, 01821, USA) in order to remove any activated carbon particles that might remain suspended in solution. The polymer solutions were then analyzed by UV spectroscopy at a wavelength of 230 nm to determine the polymer's concentration, which was used to calculate the activated carbon's polymer binding capacity. The binding capacities listed in Table S2 are the average of three measurements. nm to determine the concentration of the protein, which was used to calculate the activated carbon's protein binding capacity. The binding capacities provided in Table S3 are an average of three measurements. nm to determine the concentration of the protein, which was used to calculate the activated carbon's protein binding capacity. The binding capacities provided in Table S4 are an average of three measurements. Table S4 . Nuchar HD activated carbon's static binding capacity for α-lactalbumin at pH 5.0 and pH 9.0 and for lysozyme at pH 4.0 and pH 9.0 as the sodium chloride concentration was varied. were then used to calculate the log reduction value of the lower molecular weight protein impurity from MAb I. The recoveries and LRV provided in Table S5 are an average of three measurements. Table S5 . The recovery of MAb I and the LRV of α-lactalbumin or cytochrome C removed from solutions of MAb I with Nuchar HD activated carbon as the solution pH was varied. Table S6 are an average of three measurements. Three 15 mL centrifuge tubes for both stock solution #1 and stock solution #2 at both pH 4.0 and pH 9.0 were loaded with 10 mg of Nuchar HD activated carbon (lot number: 1339-R-09, MeadWestVaco Corporation, Richmond, VA, USA). Three separate 15 mL centrifuge tubes for both stock solution #1 and stock solution #2 at both pH 4.0 and pH 9.0 were used as controls and no activated carbon was added. Then 2.5 mL of buffer at the appropriate pH (50 mM sodium acetate for pH 4.0, 50 mM Tris-HCl for pH 9.0) was added to each tube and the tubes were subjected to vortexing. Next 2.5 mL of the appropriate stock protein solution at 10.0 mg/mL of the higher concentration protein and 1.0 mg/mL of the lower concentration proteinaceous impurity in water was added to each tube. The resulting solutions had 5.0 mg/mL of the higher concentration protein, 0.5 mg/mL of the lower concentration proteinaceous impurity, and a buffer concentration of 25 mM.
The tubes were allowed to rotate for 20 hours at room temperature. The tubes were subsequently subjected to centrifugation and the supernatant solutions were filtered through a 0.22 µm membrane (Millex® Syringe Filter Units, Millex®-GV, 0.22 µm, PVDF, 33 mm, gamma sterilized, catalogue number: SLGV033RB, EMD Millipore Corporation, Billerica, MA, 01821, USA) in order to remove any activated carbon particles that might remain suspended in solution. The concentrations of the proteins remaining in solution were determined by analytical reverse-phase chromatography as described in Experimental Section 2.5. The protein concentrations, the recovery of the higher concentration protein, and the LRV of the proteinaceous impurity are provided in Tables S7a and S7b are an average of three measurements. Table S7a . The concentrations of cytochrome C and α-lactalbumin, recovery of α-lactalbumin, LRV of the cytochrome C removed by the static treatment of a solution composed of 100,00 ppm of cytochrome C in α-lactalbumin by treatment with Nuchar HD activated carbon. Table S7b . The concentrations of cytochrome C and α-lactalbumin, recovery of cytochrome C, LRV of the α-lactalbumin removed by the static treatment of a solution composed of 100,00 ppm of α-lactalbumin in cytochrome C by treatment with Nuchar HD activated carbon. reverse-phase chromatography as described in Experimental Section 2.5. The recovery of α-lactalbumin and LRV of the cytochrome C proteinaceous impurity provided in Table S8 are an average of three measurements. Table S9 . Table S9 . The concentration of cytochrome C and α-lactalbumin in 12.5 mL fractions that were collected after a solution of 0.5 mg/mL of cytochrome C and 5.0 mg/mL of α-lactalbumin at pH 4.0 or pH 9.0 was passed through a column of Nuchar HD activated carbon. 
